News Outlets Report On R&D, Funding For Coronavirus Vaccines, Therapeutics, Recent Study Results
Bloomberg Law: Moderna Shows Positive Vaccine Result, With Hint Oxford’s Next (Langreth, 7/15).
Devex: DevExplains: Monoclonal antibody treatment for COVID-19 (Ravelo, 7/17).
Fortune: Fauci is optimistic we’ll see COVID vaccine breakthroughs by early Fall (Raimonde et al., 7/17).
The Guardian: How quickly will there be a vaccine? And what if people refuse to get it? (Renwick, 7/16).
New York Times: In Coronavirus Vaccine Race, China Strays From the Official Paths (Wee et al., 7/16).
New York Times: How a Struggling Company Won $1.6 Billion to Make a Coronavirus Vaccine (Thomas/Twohey, 7/16).
Reuters: Exclusive: J&J in talks with Japan, Gates Foundation to lock in deals on COVID-19 vaccine (O’Donnell/Mishra, 7/16).
Reuters: J&J says large study of coronavirus vaccine could begin in September (Mishra/O’Donnell, 7/16).
Reuters: Novartis to provide ‘no profit’ COVID-19 drugs to low income countries (Miller/Polityuk, 7/16).
STAT: New Covid-19 study, despite flaws, adds to case against hydroxychloroquine (Herper, 7/16).
STAT: Novartis to provide drugs for Covid-19 patients to poor countries at cost, but fails to disclose pricing (Silverman, 7/16).
Vox: Covid-19 vaccine trials are showing promising results. A lot can still go wrong (Irfan, 7/15).
Wall Street Journal: Hydroxychloroquine Didn’t Help Patients With Early and Mild Covid-19, Study Finds (Hopkins, 7/16).
Washington Post: Hydroxychloroquine studies show drug is not effective for early treatment of mild covid-19 (McGinley, 7/16).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.